ANAPTYSBIO, INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Anaptysbio, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2024.
  • Anaptysbio, Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Anaptysbio, Inc annual Income Tax Expense (Benefit) for 2023 was -$4K, a 117% decline from 2022.
  • Anaptysbio, Inc annual Income Tax Expense (Benefit) for 2022 was $24K.
  • Anaptysbio, Inc annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $9K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q4 2020 $0 $0 +$22K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$22K $0 +$51K Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-04
Q2 2020 -$73K $0 +$60K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 -$133K $0 +$19K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$152K -$22K +$170K +88.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-07
Q3 2019 -$322K -$51K -$51K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$271K -$60K -$60K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$211K -$19K -$19K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$192K -$192K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.